Fobi’s CheckPoint Solution Wins Award For Best Ticketing Technology at the 2022 Event Technology Awards in U.K. Additionally Fobi Receives $440,160 in Proceeds From Warrant Exercises

Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce that their digital ticketing solution CheckPoint has won the award for best Ticketing Technology at the 2022 Event Technology Awards.  The Event Technology Awards, which are […]

Continue Reading

ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights

ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic misfolded proteins implicated in the development of neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced its third quarter 2022 financial results and recent highlights. […]

Continue Reading

EUROPEAN COMMISSION UNVEILS BOLD AND AMBITIOUS MEDIA FREEDOM ACT – KEY CHANGES ARE NEEDED TO SAFEGUARD PRESS FREEDOM

Today, the European Commission presented the European Media Freedom Act in a bold attempt to bring the benefits of a free press to all corners of the European Union.   Angela Mills Wade, Executive Director of the European Publishers Council said: “A fundamental tenet of press freedom is a press free from political interference and government surveillance, […]

Continue Reading

TERRA BALCANICA INTERCEPTS SHALLOW POLYMETALLIC VEIN AT CUMAVICI WITHIN ITS VIOGOR-ZANIK PROJECT IN BOSNIA-HERZEGOVINA

Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA) is pleased to announce an intersection of massive polymetallic sulphide vein at the Cumavici target located within its 90% owned Viogor-Zanik project, Bosnia and Herzegovina.   Highlights   The first diamond drillhole (Drillhole CMVDD001) completed by the Company at the Viogor-Zanik project discovered a shallow polymetallic, […]

Continue Reading

UN Secretary-General to hear from youth on advancing nuclear disarmament on Hiroshima atomic bombing anniversary

6 August 2022 marks 77 years since an atomic bomb was dropped on Hiroshima. To commemorate the day, youth from across Japan will have a heart-to-heart talk with António Guterres, Secretary-General of the United Nations, about their ideas and solutions for achieving a peaceful, more secure and sustainable world – one without nuclear weapons. The […]

Continue Reading

proTunes Announces voiceLink, Online Voice Casting Connecting Ad Agencies and Brands with Top Talent Agencies

proTunes, the biggest supplier of licensable music on the planet, today announced they’re bringing the same ease they offer ad agencies and brand clients in music sourcing, to voice over casting with their new expanded offering, voiceLink. The proTunes platform is already used daily by thousands of top ad agencies and creatives. The addition of […]

Continue Reading

NEVGOLD OUTLINES THE PROJECT DEVELOPMENT PLAN AT THE ADVANCED STAGE NUTMEG MOUNTAIN GOLD PROJECT

NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce the planned development activities at the advanced stage Nutmeg Mountain Gold Project (“the Project” or “Nutmeg Mountain”) following the July 5, 2022 closing of the transaction with GoldMining Inc.   NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce […]

Continue Reading

NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in David E. Olson’s Lab

NemaLife Inc., a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.   NemaLife will evaluate the efficacy of these compounds using its high-throughput C. elegans-based in vivo screening platform. This high-throughput […]

Continue Reading